Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 SEK | +1.00% | -3.81% | +6.32% |
May. 07 | Medivir Aktiebolag Approves Board Appointments | CI |
Apr. 30 | Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 * | 32.3M 2.96M | Sales 2025 * | 52.05M 4.77M | Capitalization | 339M 31.08M |
---|---|---|---|---|---|
Net income 2024 * | -75M -6.87M | Net income 2025 * | -92M -8.42M | EV / Sales 2024 * | 5.41 x |
Net cash position 2024 * | 165M 15.08M | Net cash position 2025 * | 245M 22.43M | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
-5.51
x | P/E ratio 2025 * |
-2.4
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.1% |
Latest transcript on Medivir AB
1 day | +1.00% | ||
1 week | -3.81% | ||
Current month | -3.81% | ||
1 month | +13.48% | ||
3 months | -2.60% | ||
6 months | -23.87% | ||
Current year | +6.32% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 3.03 | +1.00% | 38,739 |
24-05-07 | 3 | -4.15% | 91,682 |
24-05-06 | 3.13 | +2.62% | 53,014 |
24-05-03 | 3.05 | -3.79% | 580,373 |
24-05-02 | 3.17 | +0.63% | 168,004 |
Delayed Quote Nasdaq Stockholm, May 08, 2024 at 06:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.32% | 31.14M | |
+2.93% | 108B | |
+8.82% | 105B | |
+1.46% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |
- Stock Market
- Equities
- MVIR B Stock